Oral immunomodulating therapies in relapsing MS
The Lancet Neurology in conversation with - Un pódcast de The Lancet Group - Jueves
Categorías:
Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
